News
I look forward to participating to the ENIGMA-TRS 2 trial as a study center.” Ravi Anand, MD, chief medical officer of Newron, stated: “Newron greatly appreciates the regulatory approval of the ENIGMA ...
A phase 1/2 clinical trial of quaratusugene ozeplasmid gene therapy and atezolizumab maintenance therapy in patients with extensive stage small cell lung cancer (ES-SCLC) ...
Zaheer Khan: 'Rishabh Pant's calibre and ability never in doubt' "As an owner of LSG, I will be thinking that I need Jitesh Sharma's wicket. If he has stepped outside the crease, he is out.
Kennedy Jr. said on Tuesday that Moderna has agreed to a true placebo-controlled trial of its new COVID-19 vaccine. While noting that he was aware of concerns about the Food and Drug ...
The trial of the 21-year-old Peruvian woman was a test of whether the federal government could levy extra charges against migrants who cross the border unlawfully into areas in Texas and New ...
Presentation to Highlight Genprex's Study of Reqorsa® Gene Therapy in Combination with Tecentriq® for the Treatment of Extensive Stage Small Cell ... for the Trials in Progress portion of ...
Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.
Randomized trial of relevance of time-of-day of immunochemotherapy for progression-free and overall survival in patients with non-small cell lung cancer. Data are n (%). This is an ASCO Meeting ...
At the data cutoff, the patient with the longest survival in the trial had completed 32 cycles of therapy and had 24.3 months survival. Studies of standard-of-care (SOC) chemotherapy treatments ...
The main objective of Phase 1 clinical trials is the initial evaluation of safety in a small number of participants. These trials are usually conducted on healthy volunteers. There are exceptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results